Longevity and anti-aging research: ‘Prime time for an impact on the globe’

- Summary by Herbalmax Staff · Shared Content from news.harvard.edu

David Sinclair is among a group of researchers collaborating on a new nonprofit academy to promote aging research and drug discovery.

“We’re generally in denial that, for most of the diseases that we get these days, the root cause is aging. I don’t know 10-year-olds that get Alzheimer’s disease or heart disease.”- David Sinclair

The Harvard Gazette interviews David Sinclair, one of the pioneers of longevity research and more recently known for his Harvard study into the restoration of the Nicotinamide Adenine Dinucleotide (NAD) molecule in mouse cells, along with 16 researchers from Harvard, MIT, and other institutions around the U.S. and Europe, launched the nonprofit Academy for Health and Lifespan Research  to promote future work, ease collaborations between scientists, and ensure that governments and corporations are making decisions based on the latest facts instead of rumor, speculation, or hype.

Sinclair talks frankly about his research, convincing the FDA aging is a disease, and how he plans on controlling the exploding science of longevity.